Articles of the Month
Videos
Articles
When platelets meet candidalysin: “we just Wnt to have fun”
Bulut, O., Geckin, B. and Domínguez-Andrés, J. Allergy. First published: 24 January 2022
Climate change and global health: A call to more research and more action
Agache, I., Sampath, V., Aguilera, J., et al. Allergy. First published: 24 January 2022
World Health Organization Global Air Quality Guideline recommendations: Executive summary
Goshua, A., Akdis, C. and Nadeau, K.C. Allergy. First published: 21 January 2022
Ten year trends of national healthcare costs of asthma, allergic rhinitis and atopic eczema in 3 million Norwegians
Parr, C.L., Nystad, W., Karlstad, Ø., et al. Allergy. First published: 20 January 2022
Differential effects of lung inflammation on insulin resistance in humans and mice
Karlina, R., Flexeder, C., Musiol, S., et al. Allergy. First published: 20 January 2022
Experience-based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance?
Türk, M., Yılmaz, İ., Şahiner, Ü.M., et al. Allergy. First published: 20 January 2022
Development of the EAACI% season definition a backup for a global application
Bastl, M., Berger, M., Bastl, K., et al. Allergy. First published: 19 January 2022
TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma
Theofani, E., Semitekolou, M., Samitas, K., et al. Allergy. First published: 17 January 2022
The prevalence of non-allergic rhinitis phenotypes in the general population: a cross-sectional study
Avdeeva, K.S., Fokkens, W.J., Segboer, C.L. and Reitsma, S. Allergy. First published: 17 January 2022
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps
Lee, S.E., Hopkins, C., Mullol, J., et al. Allergy. First published: 16 January 2022
Word of mouth: oral mucosa composition in health and immune disease
Delgado-Dolset, M., Rodriguez-Coira, J. and Sanchez-Solares, J. Allergy. First published: 14 January 2022
Higher Levels of Bacterial DNA in Serum Associate with Severe and Fatal COVID-19
Lunjani, N., Albrich, W.C., Suh, N., et al. Allergy. First published: 12 January 2022
A phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study
Sindher, S.B., Kumar, D., Cao, S., et al. Allergy. First published: 11 January 2022
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
Allergen immunotherapy and/or biologicals for IgE-mediated food allergy: systematic review and meta-analysis
de Silva, D., Rodríguez del Río, P., de Jong, N.W., et al. Allergy. First published: 09 January 2022
Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (Nut CRACKER study)
Elizur, A., Appel, M.Y., Nachshon, L., et al. Allergy. First published: 09 January 2022
Prodromes as predictors of hereditary angioedema attacks
Leibovich-Nassi, I., Reshef, A., Somech, R. and Golander, H. Allergy. First published: 09 January 2022
Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study
Nanishi, M., Fujiogi, M., Freishtat, R.J., et al. Allergy. First published: 09 January 2022
Bet v 1 and other birch allergens are more resistant to proteolysis and more abundant than other birch pollen proteins
Cabrera, A., Foo, A.C., Fitzgerald, M.C. and Mueller, G.A. Allergy. First published: 07 January 2022
Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation
Huang, Y., Li, X., Zhu, L., Huang, C., et al. Allergy. First published: 07 January 2022
The past, present and future of allergic diseases in China
Zhang, L. and Akdis, C.A. Allergy. First published: 07 January 2022
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study
Horn, M.P., Jonsdottir, H.R., Brigger, D., et al. Allergy. First published: 05 January 2022
Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate-to-severe allergy
Blaiss, M.S., Juhl, R.G., Siew, L.Q., et al. Allergy. First published: 05 January 2022
Comparing biologicals for severe chronic rhinosinusitis with nasal polyps: a network meta-analysis
Boechat, J.L., Silva, D., Sousa-Pinto, B. and Delgado, L. Allergy. First published: 03 January 2022
EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities
Agache, I., Antolin-Amerigo, D., de Blay, F., et al. Allergy. First published: 02 January 2022
Successful administration of second dose of BNT162b2 COVID-19 vaccine in two patients with potential anaphylaxis to first dose
Cahill, J.A. and Kan, M.sss Allergy. First published: 29 December 2021
“Too high, too low”: the complexities of using thresholds in isolation to inform precautionary allergen (“may contain”) labels
Turner, P.J., Baumert, J.L., Beyer, K., et al. Allergy. First published: 29 December 2021
Gender specific decline in perioperative allergic reactions in Norway after withdrawal of pholcodine
Malvik, L.B., De Pater, G.H., Dahle, G.O. and Guttormsen, A.B. Allergy. First published: 28 December 2021
Development and validation of combined symptom-medication scores for allergic rhinitis
Sousa-Pinto, B., Filipe Azevedo, L., Jutel, M., et al. Allergy. First published: 21 December 2021
Citations: 1524
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Citations: 374
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Citations: 245
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752
Citations: 190
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844
Citations: 149
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Citations: 98
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Citations: 85
Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2
Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812
Citations: 76
Type 2 immunity in the skin and lungs
Akdis, CA, Arkwright, PD, Brüggen, MC, et al. Allergy. 2020; 75: 1582– 1605
Citations: 71
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444
Citations: 69
Towards a more precise diagnosis of hypersensitivity to beta-lactams — an EAACI position paper
Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Unexplained recurrent fever: when is autoinflammation the explanation?
Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750
Eleven faces of coronavirus disease 2019
Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709
Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course
Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston, S.,L. Allergy. 2020; 75: 1543-1545
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study
Horn, MP, Jonsdottir, HR, Brigger, D, et al. Allergy. First published: 05 January 2022
Mast cell activation is associated with post-acute COVID-19 syndrome
Wechsler, J.B., Butuci, M., Wong, A., Kamboj, A.P. and Youngblood, B.A. Allergy. First published: 25 November 2021
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses
Hein, S, Herrlein, M-L, Mhedhbi, I, et al. Allergy. First published: 25 November 2021
The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID-19 vaccines
Cabanillas, B., Novak, N. and Akdis, C.A. Allergy. First published: 24 November 2021
Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis
Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy
Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021
Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways
Aliee, H., Massip, F., Qi, C., et al. Allergy. First published: 26 October 2021
The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine
Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021
RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021
Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19
Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021
What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders
Maggi, E, Azzarone, BG, Canonica, GW, Moretta, L. Allergy. First published: 28 September 2021
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Junior Members Corner
Dear Juniors,
Despite these challenging times, EAACI is keeping up with several scientific activities, aiming to being able to meet you all in person soon! The next upcoming appointments are:
- EAACI Pediatric Allergy and Asthma Meeting (PAAM) digital 2021:
It will take place on 12–13 November 2021, in an interactive hybrid format that will allow you to take part in scientific discussions both on-site both from the safety of your home through an innovative and highly interactive concept. The aim is to share new research and findings with internationally renowned experts in the common effort to come up with solutions to the most pressing challenges in the evolving pediatric field.
You can find any information about PAAM by clicking here
- 20th Immunology Winter School on Basic Immunology Research in Allergy and Clinical Immunology:
It will take place from 27 to 30 January 2022, in Semmering (Austria) in an interactive hybrid format. The event will gather 70 young researchers, PhD students and junior postdoc, active in the field of allergy, asthma, clinical immunology/immune deficiency with a focus on basic and/or clinical immunology. The participants will be selected on the basis of the quality of their submitted abstracts.
You can submit your abstract until the 7th of November by clicking here
We look forward to seeing you at our incoming activities and working together to ensure that the highest standards of care are implemented and shared within our specialty.
Best regards,
The Junior Member Assembly
